{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:51:58Z","timestamp":1792075918318,"version":"4.4.0"},"reference-count":72,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T00:00:00Z","timestamp":1514332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,15]]},"DOI":"10.1093\/jpids\/pix107","type":"journal-article","created":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T23:14:52Z","timestamp":1510960492000},"page":"159-164","source":"Crossref","is-referenced-by-count":91,"title":["Mucormycosis in Children: Review and Recommendations for Management"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9302-4543","authenticated-orcid":false,"given":"Joshua R","family":"Francis","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Royal Darwin Hospital, Darwin, Australia"},{"name":"Menzies School of Health Research, Charles Darwin University, Darwin, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Villanueva","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Royal Children\u2019s Hospital, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Bryant","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Royal Children\u2019s Hospital, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C","family":"Blyth","sequence":"additional","affiliation":[{"name":"Department of Paediatric Infectious Diseases, Princess Margaret Hospital for Children, Perth, Australia"},{"name":"School of Medicine, University of Western Australia, Perth"},{"name":"Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,12,27]]},"reference":[{"key":"key\n\t\t\t\t20180515114553_CIT0001","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1469-0691.2009.02988.x","article-title":"Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices","volume":"15","author":"Pongas","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180515114553_CIT0002","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180515114553_CIT0003","first-page":"175","article-title":"Epidemiology and treatment approaches in management of invasive fungal infections","volume":"3","author":"Kriengkauykiat","year":"2011","journal-title":"Clin Epidemiol"},{"key":"key\n\t\t\t\t20180515114553_CIT0004","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3201\/eid2007.140087","article-title":"Population-based analysis of invasive fungal infections, France, 2001\u20132010","volume":"20","author":"Bitar","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20180515114553_CIT0005","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/myc.12222","article-title":"Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin combination therapies","volume":"57","author":"Abidi","year":"2014","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20180515114553_CIT0006","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180515114553_CIT0007","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cmi.2016.01.005","article-title":"Mucormycosis in Australia: contemporary epidemiology and outcomes","volume":"22","author":"Kennedy","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180515114553_CIT0008","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180515114553_CIT0009","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180515114553_CIT0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3201\/eid2003.131230","article-title":"Invasive fungal infections after natural disasters","volume":"20","author":"Benedict","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20180515114553_CIT0011","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1469-0691.2009.02981.x","article-title":"Invasive zygomycosis in neonates and children","volume":"15","author":"Roilides","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180515114553_CIT0012","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/INF.0b013e318062115c","article-title":"Zygomycosis in children: a systematic review and analysis of reported cases","volume":"26","author":"Zaoutis","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180515114553_CIT0013","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12281-015-0239-9","article-title":"Gastrointestinal mucormycosis in neonates: a review","volume":"9","author":"Vallabhaneni","year":"2015","journal-title":"Curr Fungal Infect Rep"},{"key":"key\n\t\t\t\t20180515114553_CIT0014","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/s12879-016-2005-1","article-title":"Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries","volume":"16","author":"Pana","year":"2016","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180515114553_CIT0015","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2217\/fmb.14.23","article-title":"Laboratory diagnosis of mucormycosis: current status and future perspectives","volume":"9","author":"Lackner","year":"2014","journal-title":"Future Microbiol"},{"key":"key\n\t\t\t\t20180515114553_CIT0016","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180515114553_CIT0017","doi-asserted-by":"crossref","first-page":"810.e1","DOI":"10.1016\/j.cmi.2015.12.006","article-title":"Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF)","volume":"22","author":"Millon","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180515114553_CIT0018","doi-asserted-by":"crossref","first-page":"O336","DOI":"10.1111\/1469-0691.12408","article-title":"Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival","volume":"20","author":"Vironneau","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180515114553_CIT0019","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/ans.13264","article-title":"Challenges in the management of invasive pulmonary zygomycosis: the Alfred experience","volume":"85","author":"Saxena","year":"2015","journal-title":"ANZ J Surg"},{"key":"key\n\t\t\t\t20180515114553_CIT0020","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0003-4975(94)90243-7","article-title":"Pulmonary mucormycosis: results of medical and surgical therapy","volume":"57","author":"Tedder","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20180515114553_CIT0021","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0031-1295717","article-title":"Pulmonary mucormycosis","volume":"32","author":"Hamilos","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180515114553_CIT0022","first-page":"2016","article-title":"Primary cutaneous mucormycosis in an immunocompetent patient","author":"Paduraru","year":"2016","journal-title":"BMJ Case Rep"},{"key":"key\n\t\t\t\t20180515114553_CIT0023","first-page":"155","article-title":"Cutaneous mucormycosis","volume":"11","author":"Skiada","year":"2013","journal-title":"Skinmed"},{"key":"key\n\t\t\t\t20180515114553_CIT0024","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jcms.2012.03.019","article-title":"The surgical management of rhinocerebral mucormycosis","volume":"41","author":"Abu El-Naaj","year":"2013","journal-title":"J Craniomaxillofac Surg"},{"key":"key\n\t\t\t\t20180515114553_CIT0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jiph.2012.08.004","article-title":"Gastrointestinal mucormycosis: a success story and appraisal of concepts","volume":"6","author":"Goel","year":"2013","journal-title":"J Infect Public Health"},{"key":"key\n\t\t\t\t20180515114553_CIT0026","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0971-9261.102329","article-title":"Unsuspected invasive neonatal gastrointestinal mucormycosis: a clinicopathological study of six cases from a tertiary care hospital","volume":"17","author":"Patra","year":"2012","journal-title":"J Indian Assoc Pediatr Surg"},{"key":"key\n\t\t\t\t20180515114553_CIT0027","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1469-0691.2009.02984.x","article-title":"In vitro activity of antifungals against Zygomycetes","volume":"15","author":"Alastruey-Izquierdo","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180515114553_CIT0028","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/jac\/dks137","article-title":"In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs","volume":"67","author":"Drogari-Apiranthitou","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180515114553_CIT0029","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.inf.0000153183.51258.b8","article-title":"Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections","volume":"24","author":"Wiley","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180515114553_CIT0030","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","article-title":"Liposomal amphotericin B (AmBisome): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions","volume":"76","author":"Stone","year":"2016","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20180515114553_CIT0031","first-page":"CD006343","article-title":"Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections","author":"Blyth","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180515114553_CIT0032","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1093\/cid\/cir885","article-title":"Combination therapy for mucormycosis: why, what, and how","volume":"54","author":"Spellberg","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180515114553_CIT0033","first-page":"207","article-title":"Mucormycosis in hematologic patients","volume":"89","author":"Pagano","year":"2004","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20180515114553_CIT0034","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/AAC.45.12.3487-3496.2001","article-title":"Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study","volume":"45","author":"Walsh","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180515114553_CIT0035","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/jac\/dkv236","article-title":"Prospective pilot study of high-dose (10 mg\/kg\/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis","volume":"70","author":"Lanternier","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180515114553_CIT0036","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/JCM.06133-11","article-title":"Antifungal susceptibility and phylogeny of opportunistic members of the order Mucorales","volume":"50","author":"Vitale","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180515114553_CIT0037","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/1040841X.2012.711741","article-title":"Mucormycosis treated with posaconazole: review of 96 case reports","volume":"39","author":"Vehreschild","year":"2013","journal-title":"Crit Rev Microbiol"},{"key":"key\n\t\t\t\t20180515114553_CIT0038","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.50.1.126-133.2006","article-title":"Posaconazole as salvage therapy for zygomycosis","volume":"50","author":"Greenberg","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180515114553_CIT0039","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1086\/500212","article-title":"Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases","volume":"42","author":"van Burik","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180515114553_CIT0040","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1128\/AAC.05956-11","article-title":"In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole","volume":"56","author":"Salas","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180515114553_CIT0041","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1128\/AAC.47.11.3647-3650.2003","article-title":"Activity of posaconazole in treatment of experimental disseminated zygomycosis","volume":"47","author":"Dannaoui","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180515114553_CIT0042","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1128\/AAC.00581-15","article-title":"Superior serum concentrations with posaconazole delayed-release tablets compared to suspension formulation in hematological malignancies","volume":"59","author":"Cumpston","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180515114553_CIT0043","doi-asserted-by":"crossref","first-page":"6767","DOI":"10.1128\/AAC.03569-14","article-title":"Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis","volume":"58","author":"Lewis","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180515114553_CIT0044","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s40265-014-0227-3","article-title":"Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications","volume":"74","author":"Autmizguine","year":"2014","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20180515114553_CIT0045","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1345\/aph.1R775","article-title":"Posaconazole therapeutic drug monitoring in pediatric patients and young adults with cancer","volume":"47","author":"Bernardo","year":"2013","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t20180515114553_CIT0046","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/CMR.00046-13","article-title":"Tissue penetration of antifungal agents","volume":"27","author":"Felton","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20180515114553_CIT0047","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/AAC.00454-06","article-title":"Posaconazole plasma concentrations in juvenile patients with invasive fungal infection","volume":"51","author":"Krishna","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180515114553_CIT0048","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s10096-010-0957-4","article-title":"Posaconazole salvage treatment in paediatric patients: a multicentre survey","volume":"29","author":"Lehrnbecher","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180515114553_CIT0049","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/phar.1652","article-title":"Isavuconazole: pharmacology, pharmacodynamics, and current clinical experience with a new triazole antifungal agent","volume":"35","author":"Rybak","year":"2015","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t20180515114553_CIT0050","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180515114553_CIT0051","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180515114553_CIT0052","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s40265-016-0652-6","article-title":"Isavuconazole: a review in invasive aspergillosis and mucormycosis","volume":"76","author":"Shirley","year":"2016","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20180515114553_CIT0053","first-page":"163","article-title":"Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections","volume":"6","author":"Falci","year":"2013","journal-title":"Infect Drug Resist"},{"key":"key\n\t\t\t\t20180515114553_CIT0054","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.idc.2015.10.011","article-title":"Mucormycoses","volume":"30","author":"Farmakiotis","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"key\n\t\t\t\t20180515114553_CIT0055","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1177\/1060028016655425","article-title":"Breaking the mold: a review of mucormycosis and current pharmacological treatment options","volume":"50","author":"Riley","year":"2016","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t20180515114553_CIT0056","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1182\/blood-2011-03-316430","article-title":"How I treat mucormycosis","volume":"118","author":"Kontoyiannis","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180515114553_CIT0057","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1128\/AAC.00492-08","article-title":"Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro","volume":"52","author":"Perkhofer","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180515114553_CIT0058","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/AAC.00595-07","article-title":"Synergistic effect of posaconazole and caspofungin against clinical zygomycetes","volume":"51","author":"Guembe","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180515114553_CIT0059","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1128\/AAC.01124-08","article-title":"Posaconazole mono- or combination therapy for treatment of murine zygomycosis","volume":"53","author":"Ibrahim","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180515114553_CIT0060","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.3324\/haematol.2012.083063","article-title":"Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FungiScope registries","volume":"98","author":"Pagano","year":"2013","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20180515114553_CIT0061","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/AAC.49.2.721-727.2005","article-title":"Caspofungin inhibits Rhizopus oryzae 1,3-beta-d-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis","volume":"49","author":"Ibrahim","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180515114553_CIT0062","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1128\/AAC.49.2.830-832.2005","article-title":"Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice","volume":"49","author":"Spellberg","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180515114553_CIT0063","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.01458-07","article-title":"Combination echinocandin-polyene treatment of murine mucormycosis","volume":"52","author":"Ibrahim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180515114553_CIT0064","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180515114553_CIT0065","doi-asserted-by":"crossref","first-page":"811.e1","DOI":"10.1016\/j.cmi.2016.03.029","article-title":"Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis","volume":"22","author":"Kyvernitakis","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180515114553_CIT0066","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/cid\/cir867","article-title":"Healthcare-associated mucormycosis","volume":"54","author":"Rammaert","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180515114553_CIT0067","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1469-0691.2009.02982.x","article-title":"Outbreaks of zygomycosis in hospitals","volume":"15","author":"Antoniadou","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180515114553_CIT0068","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jhin.2012.04.007","article-title":"Outbreak of cutaneous zygomycosis associated with the use of adhesive tape in haematology patients","volume":"81","author":"Lalayanni","year":"2012","journal-title":"J Hosp Infect"},{"key":"key\n\t\t\t\t20180515114553_CIT0069","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/INF.0000000000000261","article-title":"Mucormycosis outbreak associated with hospital linens","volume":"33","author":"Duffy","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180515114553_CIT0070","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/pbc.25673","article-title":"Investigation and management of a rhizomucor outbreak in a pediatric cancer hospital in Egypt","volume":"63","author":"El-Mahallawy","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"key\n\t\t\t\t20180515114553_CIT0071","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/eci.12467","article-title":"Healthcare-associated outbreaks due to Mucorales and other uncommon fungi","volume":"45","author":"Davoudi","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"key\n\t\t\t\t20180515114553_CIT0072","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/7\/2\/159\/24815974\/pix107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T05:23:40Z","timestamp":1570339420000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/7\/2\/159\/4780392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,27]]},"references-count":72,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,12,27]]},"published-print":{"date-parts":[[2018,5,15]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/pix107","relation":{},"ISSN":["2048-7193","2048-7207"],"issn-type":[{"value":"2048-7193","type":"print"},{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2017,12,27]]}}}